Overview
PAVM market data
Price History
PAVM price chart
Valuation & Profitability
- P/E (TTM)
- 84.80 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.60 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.67 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -21,914.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.85 – $28.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $34M · P/B 0.19 · P/S 400.06.
Company News
8-K filing — PAVmed Inc. (PAVM)SEC EDGAR · Aug 14, 2026, 2:44 PM
PAVmed Q2 2026 Earnings Call: Complete TranscriptBenzinga · Aug 14, 2026, 12:59 PM
PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K EstimateBenzinga · Aug 14, 2026, 12:01 PM
PAVmed Q1 2026 Earnings Call TranscriptBenzinga · May 15, 2026, 2:15 PM
PAVmed Q1 Adj. EPS $(1.17) Misses $(0.70) Estimate, Sales $22.000K Miss $74.000K Estimate.Benzinga · May 15, 2026, 12:05 PM
Earnings Scheduled For May 15, 2026Benzinga · May 15, 2026, 11:15 AM